Evidence map›Paper›PMID 38702079›Full record

ArticleBMJ open2024

Burden of COVID-19 pandemic on tuberculosis hospitalisation patterns at a tertiary care hospital in Rajasthan, India: a retrospective analysis.

Sumit Rajotiya, Shivang Mishra, Anurag Kumar Singh, Sourav Debnath, Preeti Raj, Pratima Singh, Hemant Bareth, Prashant Nakash, Anupama Sharma, Mahaveer Singh and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sumit RajotiyaDepartment of Pharmacy Practice, NIMS University, Jaipur, Rajasthan, India.ORCID 0009-0001-2080-9953
Shivang MishraDepartment of Pharmacy Practice, NIMS University, Jaipur, Rajasthan, India.ORCID 0009-0002-4914-1958
Anurag Kumar SinghDepartment of Pharmacy Practice, NIMS University, Jaipur, Rajasthan, India.
Sourav DebnathDepartment of Pharmacy Practice, NIMS University, Jaipur, Rajasthan, India.
Preeti RajDepartment of Public health, School of Health Sciences, University of Manchester, Manchester, UK.
Pratima SinghSchool of Public Health, University of Alberta, Edmonton, Alberta, Canada.
Hemant BarethDepartment of Pharmacy Practice, NIMS University, Jaipur, Rajasthan, India.
Prashant NakashDepartment of Pharmacy Practice, NIMS University, Jaipur, Rajasthan, India.
Anupama SharmaDepartment of Biochemistry, NIMS University, Jaipur, Rajasthan, India.
Mahaveer SinghDepartment of Endocrinology, NIMS University, Jaipur, Rajasthan, India.
Deepak NathiyaDepartment of Pharmacy Practice, NIMS University, Jaipur, Rajasthan, India.
Nalin JoshiDepartment of Respiratory Medicine, NIMS University, Jaipur, Rajasthan, India dr_njoshi@yahoo.co.in.
Balvir Singh TomarDepartment of Clinical Studies, Fourth Hospital of Yulin (Xingyuan), Yulin, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to investigate the burden of the COVID-19 pandemic on tuberculosis (TB) trends, patient demographics, disease types and hospitalisation duration within the Respiratory Medicine Department over three distinct phases: pre-COVID-19, COVID-19 and post-COVID-19.

designRetrospective analysis using electronic medical records of patients with TB admitted between June 2018 and June 2023 was done to explore the impact of COVID-19 on patients with TB. The study employed a meticulous segmentation into pre-COVID-19, COVID-19 and post-COVID-19 eras.

settingNational Institute of Medical Science Hospital in Jaipur, Rajasthan, India. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome includes patients admitted to the Respiratory Medicine Department of the hospital and secondary outcome involves the duration of hospital stay.

resultsThe study encompassed 1845 subjects across the three eras, revealing a reduction in TB incidence during the post-COVID-19 era compared with the pre-COVID-19 period (p<0.01). Substantial demographic shifts were observed, with 5.2% decline in TB incidence among males in the post-COVID-19 era (n=529) compared with the pre-COVID-19 era (n=606). Despite the decrease, overall TB incidence remained significantly higher in males (n=1460) than females (n=385), with consistently elevated rates in rural (65.8%) as compared with the urban areas (34.2%). Extended hospital stays were noted in the post-COVID-19 era compared with the pre-COVID-19 era (p<0.01).

conclusionThe study underscores the influence of the COVID-19 pandemic on the TB landscape and hospitalisation dynamics. Notably, patient burden of TB declined during the COVID-19 era, with a decline in the post-COVID-19 era compared with the pre-COVID-19 era. Prolonged hospitalisation in the post-COVID-19 period indicates the need for adaptive healthcare strategies and the formulation of public health policies in a post-pandemic context. These findings contribute to a comprehensive understanding of the evolving TB scenario, emphasising the necessity for tailored healthcare approaches in the aftermath of a global health crisis.

Indexed as

COVID-19HospitalizationSARS-CoV-2Tertiary Care CentersTuberculosisAdolescentAdultAgedFemaleHumansIncidenceIndiaLength of StayMaleMiddle AgedPandemicsCOVID-19Public healthTuberculosis

Identifiers

PMID38702079
PMCPMC11086464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.